Resmetirom improves liver fibrosis in nonalcoholic steatohepatitis
1. In this randomized controlled trial, among patients with nonalcoholic steatohepatitis (NASH) with liver fibrosis, resmetirom was superior to placebo ...
Tag: Non-alcoholic steatohepatitis (NASH)
Bariatric metabolic surgery more effective than medical therapy and lifestyle modifications for non-alcoholic steatohepatitis
1. Patients in the sleeve gastrectomy and Roux-en-Y bypass groups reported significantly greater resolution of NASH compared to those in ...
Semaglutide associated with dose-dependent weight loss and resolution of nonalcoholic steatohepatitis
1. Nonalcoholic steatohepatitis (NASH) resolution without worsening of fibrosis occurred in a significantly greater percentage of patients who received semaglutide ...
Intestinal virome signature associated with severity of nonalcoholic fatty liver disease
1. The gut virome among patients with severe NAFLD was found to be different than those with milder NAFLD. #2. ...
#VisualAbstract: Obeticholic acid for the treatment of non-alcoholic steatohepatitis
1. Obeticholic acid, a farnesoid X receptor agonist, prompts fibrosis improvement in patients with non-alcoholic steatohepatitis (NASH) Evidence Rating Level: 1 ...
Obeticholic acid for the treatment of non-alcoholic steatohepatitis
1. Obeticholic acid, a farnesoid X receptor agonist, prompts fibrosis improvement in patients with non-alcoholic steatohepatitis (NASH) Evidence Rating Level: 1 ...